FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088409838> ?p ?o ?g. }

• W2088409838 endingPage "45" @default.
• W2088409838 startingPage "44" @default.
• W2088409838 abstract "<b>Objective: </b> To evaluate the efficacy and tolerability of levetiracetam (LEV) as adjunctive therapy in children (4 to 16 years) with treatment-resistant partial-onset seizures. <b>Methods: </b> This multicenter, randomized, placebo-controlled trial consisted of an 8-week baseline period followed by a 14-week double-blind treatment period. During the treatment period, patients received either placebo or LEV add-on therapy and were up-titrated to a target dose of 60 mg/kg/day. <b>Results: </b> One hundred ninety-eight patients (intent-to-treat population) provided evaluable data. The reduction in partial-onset seizure frequency per week for LEV adjunctive therapy over placebo adjunctive therapy was significant (26.8%; <i>p</i> = 0.0002; 95% CI 14.0% to 37.6%). A 50% or greater reduction of partial seizure frequency per week was attained in 44.6% of the LEV group (45/101 patients), compared with 19.6% (19/97 patients) receiving placebo (<i>p</i> = 0.0002). Seven (6.9%) LEV-treated patients were seizure-free during the entire double-blind treatment period, compared with one (1.0%) placebo-treated patient. One or more adverse events were reported by 88.1% of LEV-treated patients and 91.8% of placebo patients. The most common treatment-emergent adverse events were somnolence, accidental injury, vomiting, anorexia, hostility, nervousness, rhinitis, cough, and pharyngitis. A similar number of patients in each group required a dose reduction or withdrew from the study as a result of an adverse event. <b>Conclusion: </b> Levetiracetam adjunctive therapy administered at 60 mg/kg/day is efficacious and well tolerated in children with treatment-resistant partial seizures." @default.
• W2088409838 created "2016-06-24" @default.
• W2088409838 creator A5010629095 @default.
• W2088409838 creator A5030197967 @default.
• W2088409838 creator A5064851379 @default.
• W2088409838 creator A5083168810 @default.
• W2088409838 date "1990-07-07" @default.
• W2088409838 modified "2023-10-17" @default.
• W2088409838 title "Patterns of disease activity in multiple sclerosis." @default.
• W2088409838 cites W1973786451 @default.
• W2088409838 cites W1998757180 @default.
• W2088409838 cites W2005020945 @default.
• W2088409838 cites W2043420835 @default.
• W2088409838 cites W2066433792 @default.
• W2088409838 cites W2070410105 @default.
• W2088409838 cites W2072682344 @default.
• W2088409838 doi "https://doi.org/10.1136/bmj.301.6742.44-a" @default.
• W2088409838 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1663381" @default.
• W2088409838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2383714" @default.
• W2088409838 hasPublicationYear "1990" @default.
• W2088409838 type Work @default.
• W2088409838 sameAs 2088409838 @default.
• W2088409838 citedByCount "13" @default.
• W2088409838 countsByYear W20884098382015 @default.
• W2088409838 countsByYear W20884098382016 @default.
• W2088409838 countsByYear W20884098382019 @default.
• W2088409838 countsByYear W20884098382021 @default.
• W2088409838 countsByYear W20884098382022 @default.
• W2088409838 crossrefType "journal-article" @default.
• W2088409838 hasAuthorship W2088409838A5010629095 @default.
• W2088409838 hasAuthorship W2088409838A5030197967 @default.
• W2088409838 hasAuthorship W2088409838A5064851379 @default.
• W2088409838 hasAuthorship W2088409838A5083168810 @default.
• W2088409838 hasBestOaLocation W20884098382 @default.
• W2088409838 hasConcept C126322002 @default.
• W2088409838 hasConcept C142724271 @default.
• W2088409838 hasConcept C197934379 @default.
• W2088409838 hasConcept C204787440 @default.
• W2088409838 hasConcept C27081682 @default.
• W2088409838 hasConcept C2778375690 @default.
• W2088409838 hasConcept C2908647359 @default.
• W2088409838 hasConcept C3018162438 @default.
• W2088409838 hasConcept C42219234 @default.
• W2088409838 hasConcept C71924100 @default.
• W2088409838 hasConcept C99454951 @default.
• W2088409838 hasConceptScore W2088409838C126322002 @default.
• W2088409838 hasConceptScore W2088409838C142724271 @default.
• W2088409838 hasConceptScore W2088409838C197934379 @default.
• W2088409838 hasConceptScore W2088409838C204787440 @default.
• W2088409838 hasConceptScore W2088409838C27081682 @default.
• W2088409838 hasConceptScore W2088409838C2778375690 @default.
• W2088409838 hasConceptScore W2088409838C2908647359 @default.
• W2088409838 hasConceptScore W2088409838C3018162438 @default.
• W2088409838 hasConceptScore W2088409838C42219234 @default.
• W2088409838 hasConceptScore W2088409838C71924100 @default.
• W2088409838 hasConceptScore W2088409838C99454951 @default.
• W2088409838 hasIssue "6742" @default.
• W2088409838 hasLocation W20884098381 @default.
• W2088409838 hasLocation W20884098382 @default.
• W2088409838 hasLocation W20884098383 @default.
• W2088409838 hasLocation W20884098384 @default.
• W2088409838 hasOpenAccess W2088409838 @default.
• W2088409838 hasPrimaryLocation W20884098381 @default.
• W2088409838 hasRelatedWork W1990197915 @default.
• W2088409838 hasRelatedWork W2085830368 @default.
• W2088409838 hasRelatedWork W2087016115 @default.
• W2088409838 hasRelatedWork W2305775430 @default.
• W2088409838 hasRelatedWork W2349164817 @default.
• W2088409838 hasRelatedWork W2427186628 @default.
• W2088409838 hasRelatedWork W2465571689 @default.
• W2088409838 hasRelatedWork W3000123036 @default.
• W2088409838 hasRelatedWork W3191427281 @default.
• W2088409838 hasRelatedWork W4311628015 @default.
• W2088409838 hasVolume "301" @default.
• W2088409838 isParatext "false" @default.
• W2088409838 isRetracted "false" @default.
• W2088409838 magId "2088409838" @default.
• W2088409838 workType "article" @default.